JP2024546195A5 - - Google Patents
Info
- Publication number
- JP2024546195A5 JP2024546195A5 JP2024539899A JP2024539899A JP2024546195A5 JP 2024546195 A5 JP2024546195 A5 JP 2024546195A5 JP 2024539899 A JP2024539899 A JP 2024539899A JP 2024539899 A JP2024539899 A JP 2024539899A JP 2024546195 A5 JP2024546195 A5 JP 2024546195A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111658903.5A CN114213424B (zh) | 2021-12-30 | 2021-12-30 | 一种呋喃[3，2-b]并吡啶衍生物的合成方法 |
| CN202111658903.5 | 2021-12-30 | ||
| PCT/CN2022/139966 WO2023125102A1 (zh) | 2021-12-30 | 2022-12-19 | 1H-呋喃并[3,2-b]咪唑并[4,5-d]吡啶化合物的合成方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546195A JP2024546195A (ja) | 2024-12-17 |
| JPWO2023125102A5 JPWO2023125102A5 (https=) | 2025-12-26 |
| JP2024546195A5 true JP2024546195A5 (https=) | 2025-12-26 |
Family
ID=80707144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539899A Pending JP2024546195A (ja) | 2021-12-30 | 2022-12-19 | １ｈ－フロ［３，２－ｂ］イミダゾ［４，５－ｄ］ピリジン化合物の合成方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250171458A1 (https=) |
| EP (1) | EP4509509A1 (https=) |
| JP (1) | JP2024546195A (https=) |
| KR (1) | KR20240129021A (https=) |
| CN (2) | CN114213424B (https=) |
| AU (1) | AU2022426316A1 (https=) |
| CA (1) | CA3244846A1 (https=) |
| IL (1) | IL313966A (https=) |
| MX (1) | MX2024008276A (https=) |
| WO (1) | WO2023125102A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102399848B1 (ko) | 2016-10-03 | 2022-05-19 | 하이라이트ll 파머슈티컬 (하이난) 컴퍼니, 리미티드 | 신규한 jak1 선택적 억제제 및 그 용도 |
| CN114213424B (zh) * | 2021-12-30 | 2023-05-26 | 杭州高光制药有限公司 | 一种呋喃[3，2-b]并吡啶衍生物的合成方法 |
| WO2025224600A1 (en) * | 2024-04-21 | 2025-10-30 | Biohaven Therapeutics Ltd. | Treatment of alpha-synucleinopathies and neuroprotection |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007039146A1 (en) * | 2005-09-23 | 2007-04-12 | Smithkline Beecham Corporation | 4-carboxy pyrazole derivatives as anti-viral agents |
| WO2011138657A1 (en) * | 2010-05-04 | 2011-11-10 | Glenmark Pharmaceuticals S.A. | Aryl substituted olefinic compounds as pde10a inhibitors |
| JP6057907B2 (ja) * | 2011-10-04 | 2017-01-11 | 株式会社ヤクルト本社 | チアゾリジン誘導体又はその塩を有効成分とする医薬品 |
| CN103450125B (zh) * | 2013-07-18 | 2016-01-13 | 嘉兴中科化学有限公司 | 一种5-取代苯丙呋喃-2-羧酸及其衍生物的合成方法 |
| EP2940022B1 (en) * | 2014-04-30 | 2020-09-02 | Masarykova Univerzita | Furopyridines as inhibitors of protein kinases |
| CN105418620B (zh) * | 2014-09-23 | 2018-05-04 | 天津药明康德新药开发有限公司 | 一种4-(叔丁氧羰基)八氢呋喃并[3,2-b]吡啶-6-羧酸的合成方法 |
| WO2016100349A2 (en) * | 2014-12-16 | 2016-06-23 | Rugen Holdings (Cayman) Limited | Bicyclic azaheterocyclic compounds as nr2b nmda receptor antagonists |
| WO2016196244A1 (en) * | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
| CN106432232A (zh) * | 2016-09-18 | 2017-02-22 | 苏州汉德创宏生化科技有限公司 | 1‑哌啶‑4‑基‑1,3‑二氢‑咪唑[4,5‑b]吡啶‑2‑酮的合成方法 |
| KR102399848B1 (ko) | 2016-10-03 | 2022-05-19 | 하이라이트ll 파머슈티컬 (하이난) 컴퍼니, 리미티드 | 신규한 jak1 선택적 억제제 및 그 용도 |
| CN107216334A (zh) * | 2017-06-29 | 2017-09-29 | 上海吉尔多肽有限公司 | 一种6‑氯呋喃[3,2‑b]吡啶的合成方法 |
| CN118619944A (zh) * | 2019-06-06 | 2024-09-10 | 北京泰德制药股份有限公司 | 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物 |
| KR102785014B1 (ko) | 2019-06-06 | 2025-03-20 | 항저우 하이라이트엘엘 파마슈티컬 씨오., 엘티디. | 푸로이미다조피리딘 화합물의 합성 방법, 푸로이미다조피리딘 화합물의 결정 형태, 및 그의 염의 결정 형태 |
| IL318796A (en) | 2019-06-06 | 2025-04-01 | Hangzhou Highlightll Pharmaceutical Co Ltd | Method for preparing a furoimidazopyridine compound, polymorph and salt polymorph |
| CN114213424B (zh) * | 2021-12-30 | 2023-05-26 | 杭州高光制药有限公司 | 一种呋喃[3，2-b]并吡啶衍生物的合成方法 |
-
2021
- 2021-12-30 CN CN202111658903.5A patent/CN114213424B/zh active Active
-
2022
- 2022-12-19 MX MX2024008276A patent/MX2024008276A/es unknown
- 2022-12-19 IL IL313966A patent/IL313966A/en unknown
- 2022-12-19 CN CN202280087204.6A patent/CN118679166A/zh active Pending
- 2022-12-19 WO PCT/CN2022/139966 patent/WO2023125102A1/zh not_active Ceased
- 2022-12-19 JP JP2024539899A patent/JP2024546195A/ja active Pending
- 2022-12-19 US US18/725,431 patent/US20250171458A1/en active Pending
- 2022-12-19 CA CA3244846A patent/CA3244846A1/en active Pending
- 2022-12-19 AU AU2022426316A patent/AU2022426316A1/en active Pending
- 2022-12-19 EP EP22914356.5A patent/EP4509509A1/en active Pending
- 2022-12-19 KR KR1020247025635A patent/KR20240129021A/ko active Pending